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Abstract: Intersystem crossing (ISC) of triplet photosensitizers
is a vital process for fundamental photochemistry and photo-
dynamic therapy (PDT). Herein, we report the co-existence of
efficient ISC and long triplet excited lifetime in a heavy atom-
free bodipy helicene molecule. Via theoretical computation and
time-resolved EPR spectroscopy, we confirmed that the ISC of
the bodipy results from its twisted molecular structure and
reduced symmetry. The twisted bodipy shows intense long
wavelength absorption (e = 1.76  105m1 cm1 at 630 nm),
satisfactory triplet quantum yield (FT = 52 %), and long-lived
triplet state (tT = 492 ms), leading to unprecedented perfor-
mance as a triplet photosensitizer for PDT. Moreover, nano-
particles constructed with such helical bodipy show efficient
PDT-mediated antitumor immunity amplification with an
ultra-low dose (0.25 mgkg1), which is several hundred times
lower than that of the existing PDT reagents.
Introduction
PDT holds great promise and has attracted considerable
interest as a less invasive tumor treatment option.[1–5] When
photosensitizers are photoexcited, they react with oxygen
molecules in the microenvironment to produce singlet oxygen
(1O2), thereby eliciting nearby tumor cell death. In this
treatment, photosensitizing molecules that exhibit intense
absorption of long-wavelength light, long-lived triplet states,
and high singlet oxygen sensitization ability are essential for
the potency of the therapy.
To date, only two porphyrin-based PDT reagents have
been approved by FDA for clinical cancer treatment.[6]
However, due to their low absorption for deep-tissue-
penetrable long-wavelength light and subsequent suboptimal
singlet oxygen sensitization ability, high doses of these PDT
reagents are required for operation. For example, PpIX has
a low molar absorption efficiency (e< 5000m1 cm1) at
635 nm. Hence, high concentrations (40 mgkg1–200 mgkg1)
of 5-aminolevulinic acid (ALA, the precursor of PpIX) are
required for PDT treatment.[7] Moreover, due to the low
molar absorption coefficient (e 1170m1 cm1) at 630 nm,
Photofrin, the other FDA approved PDT reagent in clinical
practice, also suffers from the same problem of requiring high
doses for PDT treatment.[1, 7] There are great concerns that the
use of such high doses of photosensitizers can lead to
prolonged undesired patient photosensitivity and certain side
effects such as acid reflux, nausea, and flushing sensation.[6,8]
In order to reduce the required drug dose, significant
efforts have been made to develop non-porphyrin PDT
reagents that have strong absorption of long-wavelength light
and high singlet oxygen quantum yield. Yet, to date, the
effective long-wavelength-light-absorbing photosensitizers
have to rely on heavy atoms to improve their ISC (the
transition from the singlet to triplet state) and consequent
singlet oxygen generation.[9,10] For instance, metal complexes
(Pt, Ru, Ir)[11–15] and brominated/iodinated chromophores[16]
are reported. Unfortunately, besides the potential toxicity of
these heavy atoms, the dilemma here is that the improvement
of the S1!Tn ISC is often at the cost of reducing the triplet
state lifetime, as the undesired T1!S0 ISC (decay of the
triplet excited state) can be enhanced by the heavy atom
effect as well,[9] which is especially significant for those long-
wavelength-absorbing photosensitizers (Supporting Informa-
tion, Table S2). Such a shortened triplet lifetime curtailed the
reaction duration of oxygen and PDT reagents, thus being
detrimental for singlet oxygen generation and concomitant
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PDT, especially for hypoxic environments such as those in
tumors (Figure S9).[4]
To overcome this challenge, in this work, we sought to
explore the possibility to develop metal/heavy atom-free
long-wavelength-absorbing triplet photosensitizers that have
both satisfactory triplet state quantum yield and uncompro-
mised long triplet excited state lifetime. Currently, heavy
atom-free photosensitizers are known to have much longer
triplet lifetime[17] but usually poor ISC.[5] Efficient long-
wavelength heavy atom-free triplet photosensitizers are rare
(Table S3). In this study, we got inspiration from distorted
conjugated systems, which display elevated ISC efficien-
cy.[18–26] In particular, the removal of the mirror-plane
symmetry of a planar p-system is considered to allow for
a stronger spin orbit coupling (SOC) between p–p* states
with different spin manifolds (the singlet state and triplet
state), hence facilitating ISC.[27] The most notable exemplar
molecule is the buckminsterfullerene (C60), which has a heav-
ily curved p-conjugation skeleton. This molecule was report-
ed to show unity ISC efficiency but has only an extremely low
molar extinction coefficient in the visible spectral range.[21]
Another exemplar are helicenes. Helicenes are helical com-
pounds made of twisted ortho-fused aromatic rings, which
have been known to have an excellent ISC effect.[27] Yet, most
existing helicenes only absorb ultraviolet light, and it has been
quite challenging to shift absorption towards the visible/near-
infrared region.[28–31]
Herein, we report on the discovery of the co-existence of
satisfactory triplet state quantum yield and long triplet
lifetime in a heavy atom-free helicene molecule, based on
a strong and robust visible-light-harvesting bodipy chromo-
phore (helical-BDP, Figure 1). In particular, such a heavy
atom-free molecule exhibits the co-existence of satisfactory
triplet quantum yield (ISC quantum yield FT = 52%) and the
long-lived triplet state (492 ms), as well as exceptionally
intense absorption in the long-wavelength range (molar
absorption coefficient e = 1.76  105m1 cm1 at 630 nm). The
ISC mechanism of this heavy atom-free molecule was
elucidated by investigating the selective population of triplet
excited state sublevels during ISC by time-resolved electron
paramagnetic resonance (TR-EPR) spectroscopy and ad-
vanced theoretical computations. Moreover, by encapsulating
such a triplet photosensitizer in a nanoparticle, the helical
bodipy nanoparticles showed surprisingly highly efficient
PDT-augmented anti-PD-L1 antitumor immunity, with a re-
cord low dose (0.25 mgkg1). This dose is hundred times lower
than that of the PDT reagents used in the clinic and reported
in the literature (at least 0.1 mg kg1, Tables S1 and S4).
Results and Discussion
Molecular Structures
Inspired by the ISC ability of helicene and the lack of
long-wavelength-absorbing helicenes,[31,32] we were prompted
to seek new helicene structures that are based on long-
wavelength-light-harvesting chromophores and explore their
ISC properties. Bodipy is a popular fluorophore for its large
molar absorption coefficient, bright fluorescence, and excel-
lent stability. In this regard, we scrutinized few reported
bodipy derivatives with twisted p-conjugation planes (pre-
viously synthesized only as fluorophore candidates and the
ISC properties were not studied).[32–35] Among these, through
theoretical computations, we identified that a p-conjugation
framework of the naphthalene-fused bodipy derivative (hel-
ical-BDP, Figure 1), previously reported by Shen et al,[35] is
twisted in a way that is similar to that of helicene.[36–38] As
shown in Figure 1, there is a small but notable angle between
the planes shown in green and orange. This geometry is
distinctly different from the unsubstituted bodipy (BDP,
Figure 1), and those substituted bodipy derivatives that have
a strictly planar extended p-conjugation framework,[39] which
are known to have negligible ISC.[40]
With the intuition that this helical-twisted molecule
(helical-BDP, Figure 1) should inherit the strong ISC ability
from helicene, we explored its ISC capability, triplet lifetime,
and potential for PDT. The helical-BDP was prepared based
on reported methods.[35] We observed the outstanding ISC of
this twisted molecule by both nanosecond transient absorp-
tion (ns-TA) spectroscopy and singlet oxygen photosensitiz-
ing experiments. The ISC mechanism for this twisted heavy
atom-free molecule was further revealed through TR-EPR
and theoretical computations. The parent bodipy (BDP,
Figure 1) was used as a control compound throughout this
study.
Photophysical Study: Absorption, Triplet Excited States, and ISC
Kinetics
The absorption band of the helical-BDP is centered at
630 nm, with the molar absorption coefficient (1.76 
105m1 cm1) almost twice that of BDP (Figure 2a). More-
over, the vibrational progression of the helical-BDP is more
resolved than that of the BDP. Our results demonstrate that
the twisted structure clearly altered the excited state proper-
ties of the bodipy chromophore.
The triplet excited state of the helical-BDP was inves-
tigated by ns-TA spectroscopy (Figure 2b). In particular,
upon pulsed laser excitation at 628 nm, two negative bands
Figure 1. Molecular structures of helical-BDP and BDP (top) and the
side view of the RHF optimized ground structures (bottom).
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centered at 625 nm and 579 nm were observed. These are the
two ground state bleaching bands (GSB, see the steady state
absorption of the compound, Figure 2 a). In addition, a weak
excited state absorption (ESA) band in the range of 400–
550 nm was observed. This is attributed to the absorption of
the T1 triplet state (T1!Tn transition). Moreover, by mon-
itoring the decay of the GSB signal at 610 nm, the triplet
excited state was found to be long-lived (hundreds of
microseconds) in deaerated solution (inset of Figure 2b). In
contrast, in an aerated solution, the lifetime was greatly
reduced to 224 ns (Figure S2). Such a significant reduction in
its lifetime clearly confirmed the triplet state feature of the
transient species.
Notably, the intrinsic triplet state lifetime (t = 492 ms, for
details, see Supporting Information) is much longer than that
of typical heavy atom-containing triplet photosensitizers
showing long-wavelength absorption (Table S2, for instance,
tT = 1.7 ms for the 2,6-diiodo-bisstyrylbodipy). It should be
noted that heavy-atom photosensitizers tend to have a sig-
nificantly reduced triplet state lifetime (heavy-atom effect),
which is especially severe for chromophores that have long-
wavelength absorption with low triplet energy. For instance,
with iodination, the triplet lifetime of 3,5-distyrylbodipy was
significantly reduced from 72 ms to 1.7 ms (Table S2). Such
a shortened triplet lifetime is detrimental to applications, such
as oxygen sensing,[41] photocatalysis[42] and PDT,[4] as these
applications are all based on intermolecular diffusion-con-
trolled triplet energy transfer or electron transfer, for which
the efficiency is dependent on the triplet state lifetimes of the
photosensitizer. Our study shows that the 1O2 sensitization
ability (a basic process in PDT) of a triplet photosensitizer
showing a short-lived triplet state almost vanishes in hypoxic
conditions; the singlet oxygen quantum yield drops from 45%
under normal conditions to 2% under a hypoxic atmosphere.
However, this did not occur for the long-lived helical-BDP
(FD 36% in both normal atmosphere and hypoxic atmos-
phere, Figure S9). Hence, the long triplet state lifetime of the
helical bodipy shows its unique advantage over the conven-
tional method of using the heavy-atom effect. Inspired by the
excellent photophysical properties of helical-BDP, we ex-
plored the feasibility of TTA upconversion by using this
special heavy atom-free photosensitizer. Outstanding overall
red-to-yellow TTA upconversion brightness was obtained
(h = e FUC = 1296m
1 cm1 at 250 mW cm2 of 635 nm excita-
tion) with helical-BDP as an intense red-light-absorbing
photosensitizer in conjunction with perylenebisimide (PBI) as
the yellow emitter (Figures S5 and S6).
In order to study the kinetics of ISC, ns-TA spectroscopy
with higher time resolution was performed. As shown in
Figure 2c, the ESA at 525 nm is attributed to the S1!Sn
absorption band. At a longer delay time (42 ns in Figure 2c),
the shape of the spectrum resembles that of Figure 2b, clearly
showing that the ISC process takes place. Hence, the ESA
bands centered at 490 nm and 670 nm can be attributed to the
T1!Tn absorption. The ISC time constant for helical-BDP
was determined to be 1/kISC = 8 ns (Figure 2 d). According to
the population ratio of the sublevels of the triplet state
measured by TR-EPR spectra (Px/Py/Pz = 1:0:0.2, see later
section, Figure 4c), the electron spin-selective ISC rate
constants (kISC) to the triplet sublevels (Tx, Ty, Tz) of the T1
state are 0.10 ns1, 0 ns1, and 0.02 ns1, respectively. The
photophysical parameters of the compounds are listed in
Table 1.
ISC Mechanism: Theoretical Computation and TR-EPR
Spectroscopy
The geometries of the compounds were examined with the
intuition that they are pivotal to the ISC. Theoretical
computations[43, 44] show that the optimized ground-state
geometry of BDP has C2v geometry (the p-conjugation of
the Bodipy chromophore is planar); while for the helical-
BDP, the C2 geometry is most stable, followed closely by the
Figure 2. Steady-state and transient absorption spectroscopies. a) Mo-
lar extinction coefficient of helical-BDP in DCM. b) ns-TA spectra of
helical-BDP (lex = 628 nm, c= 1.25  10
6
m). Inset: Decay trace of
helical-BDP at 610 nm, c= 3.1  107 m. This was measured in deaer-
ated DCM, recorded in the co-linear measurement mode of the
LP980 ns-TA spectrometer, 20 8C. c) ns-TA spectra of helical-BDP in
toluene (lex = 640 nm) at 0 ns, 40 ns, 42 ns and 220 ns. The arrows
indicate the evolution of various bands. d) The kinetic trace at 670 nm
and 490 nm show the time constant for triplet state formation.









helical-BDP 630 17.6 649 3.3 21 % 492 36% 52%
BDP 500 8.4 512 4.1 52 % –[j] –[j] –[j]
[a] In dichloromethane (DCM), 25 8C. [b] Maximum absorption wave-
length, in nm. [c] Molar absorption coefficient, 104 m1 cm1. [d] Max-
imum fluorescence emission wavelength, in nm. [e] Luminescence
lifetimes, in nanoseconds (ns). [f ] Fluorescence quantum yield with
methyl blue as standard (FF = 3% in MeOH). [g] Intrinsic triplet excited
state lifetime, in microseconds (ms), c = 3.1  107 m, low concentration
was used to reduce the self-quenching effect. [h] Singlet oxygen quantum
yield with methyl blue as standard (FD = 57% in DCM). [i] Triplet
quantum yield determined by ns-TA spectroscopy, by triplet-triplet energy
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CS geometry (both are non-planar geometries, Table S7),
whereas the C2v geometry is a transition state.
In order to find out the relationship between the twisted
structure and the enhanced ISC, the spin-orbit coupling
(SOC) matrix elements between S1 state and the sublevels
(Tx, Ty, and Tz) of each triplet excited state were further
determined by quantum chemical calculations (listed in
Table 2). As the SOC in organic systems is considered to be
a small correction to purely nonrelativistic electronic states,[27]
the magnitude of the calculated SOC values (between the
singlet and triplet states) reflect the possibility of ISC in
a certain degree. Since T1 is below the S1 state, and T2 is
slightly above S1 by approximately 0.1 eV in both the helical-
BDP and BDP, both S1!T1 and S1!T2 are considered to be
possible pathways of ISC (Table S7). Note that according to
the CAS-Cl calculations the states S1, T1 and T2 share the
same symmetry.
The selection rules for SOC between a singlet state S and
a triplet state T require that the product of the irreducible
representation of the spatial symmetries of these two states
transform like one of the three rotations [see Supporting
Information for details; Equation (1)]:
G Sð Þ  G Tð Þ ¼ GðRx;Ry;RzÞ ð1Þ
As a consequence, in molecules with C2v geometry, SOC is
forbidden between singlet and triplet states with the same
spatial symmetry. Hence, SOC between S1/T1 or S1/T2 is
forbidden in C2v (Table 2 and Figure 3b). This rationalizes the
negligible ISC ability of the parent BDP.
With the molecular structure deviated from the C2v
geometry, these selection rules will be relaxed (Figure 3a).
Clearly, the magnitude of this coupling will depend on how
much the twisted structures deviate from the idealized C2v
geometry. For the helical-BDP, as the C2-geometry has the
lowest energy, selective population of the Tx state is expected
(see Figure 3a and Table 2). Note that Tx, Ty, Tz are three non-
degenerate sublevels of the T1 triplet state.
The overpopulation of the Tx state was experimentally
confirmed by TR-EPR (Figure 4 c). The spin selectivity of the
ISC reflects both in the electron spin polarization (ESP) of
the three sublevels of the triplet embedded in a magnetic field
and in the enhanced absorption/emission (a/e) character of
the main features of the TR-EPR transitions, as detailed in
the Supporting Information. The TR-EPR spectrum of the
triplet state of helical-BDP shows an (a, e, a, e, a, e) ESP
pattern (Figure 4a, blue line). A careful simulation reveals an
overpopulation of the Tx state (Figure 4c). The consistency
between theoretical computation and experimental TR-EPR
validate that the enhanced ISC of helical-BDP is due to the
reduced symmetry in the twisted structure. It also enables us
to deduce that the helical-BDP possesses mainly a helical
structure (C2 geometry).
Moreover, the confinement of the triplet state wave
functions of these compounds is examined, as it is crucial for
rationalization of the ISC ability of the twisted structure.[27]
Experimentally, the zero-field splitting (ZFS) parameter D-
value reflects the extension of the wave functions of the two
unpaired electrons of the triplet state. This value can be easily
obtained from the total width of the TR-EPR spectra (see
Supporting Information) of IBDP and helical-BDP (Fig-
ure 4). We clearly noticed that the width of the TR-EPR
spectrum of IBDP is quite larger than that of the helical-BDP
(D =595 G for helical-BDP and D =1050 G for IBDP,
Figure 4c). We deduce that the triplet wave function of
helical-BDP is far more delocalized than that of IBDP. This is
supported by the calculation of the spin density distribution;
Table 2: Matrix elements (in units of cm1) of the one-electron Breit–
Pauli Operator of the SOC between S1 and the lowest two triplet states.
[a]
helical-BDP BDP
SOC states C2V C2 CS C2V
S1/T1 0 0.0977 x 0.0024 z 0
S1/T2 0 0.1689 x 0.0781 z 0
[a] Each value is labeled with the index (x, y, z) of the triplet sublevel. In
both helical-BDP and BDP, SOC is forbidden by symmetry in the
structures with C2v point group (see Supporting Information for details).
Figure 3. SOC matrix elements of the first excited singlet state with the
nearest triplet states. a) SOC of helical-BDP in C2 geometry and
b) SOC of BDP in C2v geometry. The labelling of the substates are
indicated (note that every excited triplet state consists of three non-
degenerate sublevels Tx, Ty and Tz). The larger the SOC value, the
greater possibility of ISC.
Figure 4. a) TR-EPR spectra of helical-BDP (lex = 555 nm) and IBDP
(lex = 532 nm) in toluene/MeTHF (v/v, 3:1) frozen mixed solution,
c = 3.0  105 m, 80 K. The canonical orientations of each transition are
indicated (the prime indicates the ms = 0 ! ms = + 1 transitions).
b) Spin density distribution of helical-BDP and IBDP. Larger circles
indicate larger (absolute) spin density value on the atom. The ZFS
frame is also presented. c) Fitting parameters of the simulations in
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Figure 4b shows that the wave function spreads all over the p-
system of the helical-BDP. Hence, we have a true helical p-
system. This is in agreement with the significant enhancement
of ISC for the heavy atom-free helical-BDP ; it is the
delocalization of the electrons on the entire twisted molecular
framework that increases the SOC for the ISC between the
two p-p* states, as twisting the p-conjugation framework
allows for non-vanishing one-center and two-center integrals
of all atomic angular momentum operators. On the contrary,
if the triplet wave function was localized on the planar p-
conjugation framework as in the parent BDP, we would not
expect any enhancement of SOC.
Record Low-Dose PDT Augmented Checkpoint Blockade
Immunotherapy
Inspired by the exceptionally strong long-wavelength
absorption (e = 1.76  105m1 cm1 at 630 nm), satisfactory
singlet oxygen quantum yield (FD = 36%) and the long-lived
triplet state (tT = 492 ms), we explored the potential of helical-
BDP as a long-wavelength-absorbing heavy atom-free PDT
reagent to augment the checkpoint blockade immunotherapy.
Firstly, the PDT effect of helical-BDP on tumor cells were
examined in vitro. In order to encapsulate such hydrophobic
photosensitizers to be used in aqueous solution, the helical-
BDP was wrapped in the octadecylamine substituted amphi-
philic polymer (PSMA-PEG-OA) to generate such dye-
loaded nanoparticles (helical-BDP-NPs, Figure S8). These
nanoparticles showed outstanding colloidal stability (Fig-
ure S18), high dye entrapment efficiency (76%). Their singlet
oxygen quantum yields (FD) were determined to be 21%. The
fluorescence spectrum of the helical-BDP-NPs is presented in
Figure 5a and the fluorescence quantum yield (FF) is
measured to be 3.8%. The helical-BDP-NPs exhibited high
photocytotoxicity to the CT26 tumor cells (semi-lethal con-
centration IC50 = 11.5 nm) under 656 nm light irradiation,
showing remarkably improved performance (Figure 5b,c)
compared to the phthalocyanine photosensitizer IRDye
700DX, which is arguably one of the best photo-immune
therapy photosensitizers.[45]
In order to study the effect of PDT mediated checkpoint
blockade immunotherapy, a bilateral model of CT26 tumors
on BALB/c mice was established to artificially mimic meta-
stasis. The tumor that is treated with light illumination is
considered to be the “primary tumor”, and the tumor
untreated at another side is considered to mimic the
“metastatic tumor”. As shown in Figure 6b, the mice were
randomly divided into 5 groups: (1) hv only, (2) anti-PD-L1
only, (3) helical-BDP-NPs only; (4) helical-BDP-NPs + hv
only, and (5) helical-BDP-NPs + anti-PD-L1 + hv. The
therapeutic efficacies of different treatment groups were
evaluated by measuring tumor volume.
The tumor volume growth rates of the primary tumor
(treated with PDT) are presented in Figure 6e. As compared
to Group 3 (only the injection of helical-BDP-NPs) and
Group 1 (only irradiation with light, hv), the primary tumor in
Group 4 (helical-BDP-NPs + hv) shows significant inhibition
of growth, indicating that helical-BDP-NPs is a potent PDT
reagent for primary tumors.
The tumor volume growth rates of the metastatic tumor
are presented in Figure 6 f. It is impressive that although the
metastatic tumor was untreated with PDT, the combination of
immune therapy with PDT treatment on primary tumors
(Group 5 = Group 2 + Group 4) presented significant meta-
static tumor suppression (Figure 6 f) and obvious necrosis of
metastatic tumor cells (H&E staining analysis, Figure 6d).
These experimental results demonstrated that the helical-
BDP-NPs mediated PDT can significantly augment the
checkpoint blockade immunotherapy efficacy and promote
abscopal effects (Figure 6a).
Specifically, anti-PD-L1 can inhibit the interaction be-
tween PD-L1 (in tumor cells) and PD-1 (in T-cells), thus
rescue the T cells (Figure 6a).[46] However, this kind of
checkpoint blockade immunotherapy, being only effective for
tumors with the presence of T-cells, has low response rates
(10–40%).[47] On the other hand, as shown in Figure 6a, PDT
can release tumor specific antigen through tumor cells
apoptosis, inducing acute inflammation and increasing the
infiltration of T-cells.[48–51] Hence the PDT augmented the
anti-PD-L1 checkpoint blockade immunotherapy, leading to
an obviously inhibition to metastatic tumor. This is verified by
the analysis of the antitumor immunity. The immune cell
profiling in the spleen (Figure S16) shows that the cytotoxic
CD8+ T cell and helper CD4+ T cell levels significantly
increased in the treated group (Group 5) as compared to
Group 1. Moreover, in Group 5, there is a significant increase
of tumor-infiltrating CD4+ T-cells and CD8+ T-cells in both
Figure 5. PDT in vitro. a) Normalized absorption and emission spectrum of helical-BDP-NPs. Cell viability of CT26 cells pre-treated with increasing
doses of b) helical-BDP-NPs and c) IRDye 700DX with and without light irradiation. Irradiation by 656 nm LED, light dose: 6 J cm2, 20 8C.
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primary and metastatic tumors (Figure 6g,h). As a result,
a significantly increased concentration of IFN-g in Group 5
was observed (Figure S21).[52, 53] These results demonstrated
that the combined effect of helical-BDP-NPs mediated PDT
and anti-PD-L1 treatment significantly increased the infiltra-
tion of effector T cells to treat the metastasis.
More importantly, to the best of our knowledge, with this
novel triplet photosensitizer helical-BDP, PDT-mediated
antitumor immunity amplification was achieved with the
lowest drug dose reported to date (0.25 mg kg1) and an
ultralow light dose (6 Jcm2), being thousands of times lower
than other traditional/commercial PDT reagents that have
been used in the literature (> 1.4 mgkg1, > 18 J cm2,
Table S4). The highly efficient PDT effect can be attributed
to the following reasons: 1) The exceptionally high molar
extinction coefficient (e = 1.76  105m1 cm1 at 630 nm) en-
ables outstanding light harvesting to occur, 2) the super-long
triplet lifetime (tT = 492 ms) is critical and favorable toward
achieving efficient energy transfer to produce 1O2, especially
in hypoxic tumors (Figure S9), and 3) the small size of the
uniform spherical nanoparticles (31.5 5.2 nm, Figure S10) is
beneficial for their accumulation and retention in the tumor.
Collectively, super-efficient PDT was achieved.
Conclusion
In summary, our results represent a new paradigm in the
development of the next generation of triplet photosensi-
tizers. For the first time, co-existence of satisfactory ISC and
long triplet lifetime was revealed in a heavy atom-free bodipy
helicene molecule. Advanced quantum chemical calculations
and time-resolved EPR spectroscopy indicate that torsion of
the plane into a helix (C2-symmetry) enhances the ISC,
yielding the population of Tx substate. Moreover, the triplet
state wave function (spin-unpaired electrons) is found to be
delocalized over the entire twisted p-conjugate skeleton. We
showed that such a twisted bodipy helicene molecule shows
exceptionally intense long-wavelength absorption (e = 1.76 
105m1 cm1 at 630 nm, twice that of the normal unsubstituted
BDP), satisfactory triplet quantum yield (FT = 52 %) and
a long-lived triplet state (tT = 492 ms), leading to unprece-
dented performance as a triplet photosensitizer. More
importantly, by encapsulating such a heavy atom-free triplet
photosensitizer in a nanoparticle, a record low dose of the
photosensitizers (0.25 mg kg1) with an ultralow light dose
(6 J cm2) is achieved for effective PDT immunotherapy. This
dose is hundred times lower than that of the existing PDT
reagents. Taken together, this heavy atom-free triplet photo-
sensitizer shows long sought-after advantages over conven-
tionally used triplet photosensitizers. Since ISC of organic
Figure 6. PDT augmented checkpoint blockade immunotherapy. a) Schematic indicating of the helical-BDP-NPs with anti-PD-L1 for cancer
treatment. b) The experimental condition of each group (the mice were randomly divided into 5 groups). G= Group. The “ + ” represents the
condition is satisfied and the “” represents the condition is unsatisfied. c) Timeline of the treatment. d) Hematoxylin and eosin (H&E) staining
of tumor tissue sections from different treatment groups at day 15. Scale bar = 150 mm. e) Tumor volume of primary tumor. f) Tumor volume of
artificial metastatic tumor. g) Analysis the immunity CD4+ T cells and h) CD8+ T cells of metastatic tumor and primary tumor. Data are expressed
as means  s.d. (n = 5). *P<0.05, **P<0.01, and ***P<0.001.
Angewandte
ChemieResearch Articles
16119Angew. Chem. Int. Ed. 2020, 59, 16114 – 16121  2020 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
chromophores is fundamentally important in photochemistry
as well as in many other important areas such as PDT, we
believe that our study not only leads to the discovery of new
heavy atom-free photosensitizer molecular structural motifs
with unique triplet properties, it also opens up a wide variety
of opportunities in photonic/biophotonic fields.
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